This Review presents data describing the health burden of cardiovascular disease (CVD)
within and across the WHO European Region. CVD remains the most common cause of …

PET imaging of atherosclerosis can quantify several in vivo pathological processes
occurring within the arterial system. 18F-fluorodeoxyglucose (FDG) is the most-commonly …

2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …

Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the
population level or targeted at an individual, that are aimed at eliminating or minimizing the …

Kinetics of optical tweezers (OT)-induced spontaneous aggregation and disaggregation of
red blood cells (RBCs) were studied at the level of cell doublets to assess RBC interaction …

The 20th century saw cardiovascular disease ascend as the leading cause of death in the
world. In response to the new challenge that heart disease imposed, the cardiovascular …

Noncommunicable disease (NCD) scenario models are an essential part of the public health
toolkit, allowing for an estimate of the health impact of population‐level interventions that are …

This review summarizes important advances in polymer-based nanotechnologies for the
treatment and diagnosis of cardiovascular diseases, focusing on nanoparticles and …

Stroke is one of the leading causes of adult disability worldwide. After ischemic stroke,
damaged tissue surrounding the irreversibly damaged core of the infarct, the penumbra, is …

2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …